- Home
- ACHV vs IHRT Comparison
ACHV vs IHRT Comparison
Compare ACHV & IHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACHV | IHRT |
|---|---|---|
| Founded | N/A | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Broadcasting |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 726.5M | 589.5M |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ACHV | IHRT |
|---|---|---|
| Price | $8.18 | $2.39 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 3 | 2 |
| Target Price | ★ $14.67 | $4.25 |
| AVG Volume (30 Days) | ★ 1.4M | 424.8K |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 54.19 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $3,864,991,000.00 |
| Revenue This Year | N/A | $9.96 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 0.27 |
| 52 Week Low | $2.62 | $2.32 |
| 52 Week High | $8.64 | $6.56 |
Technical Indicators
Market Signals| Indicator | ACHV | IHRT |
|---|---|---|
| Relative Strength Index (RSI) | 60.88 | 32.35 |
| Support Level | $4.03 | N/A |
| Resistance Level | $8.63 | $2.90 |
| Average True Range (ATR) | 0.37 | 0.13 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 75.46 | 15.52 |
Price Performance
Historical ComparisonAbout ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.
About IHRT iHeartMedia Inc.
iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.